Home » Authors » Kim Coghill

Articles by Kim Coghill

DiaDexus, Medarex Add Three Oncology Targets To Old Deal

Sep. 17, 2004

DiaDexus, Medarex Add Three Oncology Targets To Old Deal

Sep. 17, 2004

FDA Panel Wants 'Black Box' Warnings On Antidepressants

Sep. 16, 2004

FDA Panel Wants 'Black Box' Warnings On Antidepressants

Sep. 16, 2004

FDA, Industry Ask What Makes Biogenerics Work?

Sep. 15, 2004

FDA, Industry Ask What Makes Biogenerics Work?

Sep. 15, 2004

FDA Panel Evaluates SSRIs, Risk Of Suicidal Thoughts

Sep. 14, 2004

FDA Panel Evaluates SSRIs, Risk Of Suicidal Thoughts

Sep. 14, 2004

NIH To Make Federally Funded Research Available To Public

Sep. 13, 2004

NIH To Make Federally Funded Research Available To Public

Sep. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...